Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2019 financial results after…
Christopher Heckman to focus on Oncology Center of Development as Dr. Art Wamil joins as lead neurologist RESEARCH TRIANGLE PARK,…
IRVINE, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24NVUS&src=ctag" target="_blank"gt;$NVUSlt;/agt;–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, announced today that Geert Kersten, Chief Executive…
BOSTON & MUNICH–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biomarkers?src=hash" target="_blank"gt;#biomarkerslt;/agt;–Invicro LLC, a Konica Minolta company and iTheraMedical GmbH announced a unique partnership with the…
Center for Tobacco Products incorporates machine learning platform to assist toxicology research LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP), the leading…
DUBLIN–(BUSINESS WIRE)–The “Biological Safety Testing Market Size, Share & Trends Analysis Report By Product, By Application (Vaccines & Therapeutics, Gene…
First-Quarter 2019 Worldwide Sales Were $10.8 Billion, an Increase of8%; Sales Increased 11% Excluding Negative Impact from ForeignExchange; Growth Driven by Oncology and Vaccines
First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and…
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases,…